Furthermore, it showed that the combination of JAX fecal transplantation with PD-L1 blockade enhanced tumor control, suggesting that microbiota can alter not only the antitumor immunity but also the response to PD-L1 inhibitors. The gene discussed is CD274; the disease is neoplasm.